ClearPoint Neuro (CLPT) Other Accumulated Expenses (2011 - 2026)

ClearPoint Neuro has reported Other Accumulated Expenses for 16 years, with the latest figure at $2.1 million in Q1 2026.

• Quarterly Other Accumulated Expenses rose 40.73% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 40.73% YoY) and the FY2025 annual result came in at $2.8 million, up 92.14% from the prior year.
• Other Accumulated Expenses declined to $2.1 million in Q1 2026 per CLPT's latest filing, from $2.8 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.8 million in Q4 2025 and troughed at $602000.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $1.3 million in 2024 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses surged 284.54% in 2022, then slumped 49.01% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $2.1 million in 2022, then sank by 49.01% to $1.1 million in 2023, then surged by 37.7% to $1.4 million in 2024, then surged by 92.14% to $2.8 million in 2025, then dropped by 23.73% to $2.1 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.1 million, $2.8 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.